EU legislative process

This subtopic contains a range of resources relating to EU legislative process, procedures and principles relevant to the types of legislation which fall under the umbrella of EU law, including:

  1. EU Treaties (and all their amendments)

  2. Regulations

  3. Directives

  4. Decisions

  5. Opinions and Recommendations

  6. Tertiary legislation (including implementing and delegated legislation)

EU law is developed further by the case law of the Court of Justice of the European Union and legal principles developed by it.

The EU is based on the rule of law. Actions taken by the EU are founded on Treaties approved voluntarily and democratically by all Member States. Under the principle of conferral, if a policy area is not cited in a treaty, the European Commission cannot propose a law in that area as it is not an EU competence.

There are different types of EU legal documents. A treaty is a binding agreement betweenMember States setting out EU objectives, rules for relevant EU institutions, how decisions are made and the relationship between the EU and its Member States. Amendments allow for EU enlargement, and areas of co-operation.

To view the latest version of this document and thousands of others like it, sign-in with LexisNexis or register for a free trial.

Powered by Lexis+®
Latest EU Law News

Commission publishes updated clinical trials guidance package

The European Commission's Directorate-General for Health and Food Safety has published a comprehensive package of updated clinical trials guidance documents, all endorsed by the Clinical Trials Coordination and Advisory Group (CTAG) on 15 October 2025. The package includes new recommendations on criteria for selecting a reporting Member State under Article 85(2)(c) of the Clinical Trials Regulation, establishing a workshare criterion when proposed reporting Member States decline the role, which occurs in approximately 30% of applications. The Commission has updated its recommendation paper on decentralised elements in clinical trials (Version 02), superseding the December 2022 version, with revised national provision overviews and guidance on informed consent, investigational medicinal product delivery, and remote monitoring. A new recommendation paper addresses frequent issues identified during Part I and Part II assessments, based on feedback from national competent authorities and ethics committees, covering investigational medicinal product dossiers, protocols, and safety reporting. The package also includes revised guidance on auxiliary medicinal products, effective 1 December 2025 for new applications, featuring an updated classification system distinguishing between authorised, modified authorised, and unauthorised auxiliary medicinal products with corresponding application and safety reporting requirements.

View EU Law by content type :

Popular documents